SBIR/STTR Research Award
Release of Angiogenic Inhibitors for Macular Edema
Award amount
$100,000Program and phase
SBIR · Phase IAward year
2004Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Charlesson, LLC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- EBG6FJ52JJX3
- Solicitation number
- PHS2004-2
- Topic code
- Not reported
Research abstract
DESCRIPTION (provided by applicant) Increased vascular permeability or vascular leakage in the retina is an early and common feature of diabetic retinopathy and can result in diabetic macular edema. Vascular leakage is also responsible for cystoid mac
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- Fenofibrate Eye Drop for the Treatment of Diabetic Retinopathy
- Developing A Novel Therapy for Diabetic Retinopathy
- A Novel Therapeutic Antibody for Age-related Macular Degeneration
- A Wnt Modulator for Treatment of Age-related Macular Degeneration
- Developing A Novel Therapy for Diabetic Retinopathy
Research funding history
23 SBIR/STTR records share this UEI (2004–2016). Reported award amounts total $10,337,136. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services